Loading
The 2024 update to the international pancreatic cyst guidelines, which adds faster cyst growth, new diabetes and pancreatitis to the warning signs, allows surveillance to stop in some older patients with small stable cysts, and grades each recommendation by the strength of the evidence.
Evidence-graded revision of the Fukuoka guidelines by the International Association of Pancreatology, meeting in Kyoto. High-risk stigmata are retained, with an enhancing mural nodule of 5 mm or more, main duct of 10 mm or more, obstructive jaundice and positive cytology as indications for surgery in fit patients. Worrisome features now include cyst growth of 2.5 mm or more per year, new-onset or worsening diabetes and acute pancreatitis, alongside the earlier criteria.
The guideline addresses when surveillance can be stopped (after five years of stability in cysts under 2 cm in patients who would not be surgical candidates), the role of cyst fluid molecular analysis, management after resection, and the need for randomised trials of surveillance strategies.
The current international standard for deciding which pancreatic cysts to operate on, which to watch and for how long.
Shares Intraductal papillary mucinous neoplasm and other pancreatic cystic precursors, Pancreatic ductal adenocarcinoma.
Shares Intraductal papillary mucinous neoplasm and other pancreatic cystic precursors, Pancreatic ductal adenocarcinoma.
Shares Intraductal papillary mucinous neoplasm and other pancreatic cystic precursors, Pancreatic ductal adenocarcinoma.
Shares Intraductal papillary mucinous neoplasm and other pancreatic cystic precursors, Pancreatic ductal adenocarcinoma.
Shares Intraductal papillary mucinous neoplasm and other pancreatic cystic precursors, Pancreatic ductal adenocarcinoma.
Shares Intraductal papillary mucinous neoplasm and other pancreatic cystic precursors, Pancreatic ductal adenocarcinoma.
Shares Intraductal papillary mucinous neoplasm and other pancreatic cystic precursors, Pancreatic ductal adenocarcinoma.
Shares Intraductal papillary mucinous neoplasm and other pancreatic cystic precursors, Pancreatic ductal adenocarcinoma.